JPRN-UMIN000042812已完成未知
Efficacy of dulaglutide after switching from incretin related drugs in patients with type 2 diabetes - Efficacy of dulaglutide after switching from incretin related drugs in patients with type 2 diabetes
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 101
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Subjects in whom antidiabetic agents other than GLP-1 RAs or DPP-4 inhibitors were changed during the observation period
研究者
相似试验
已完成
不适用
Efficacy and safety of dulaglutide when used instead of exenatide extended-release in type 2 diabetic patientsType 2 diabetes mellitusJPRN-UMIN000019031Haga Diabetes Clinic40
已完成
不适用
Efficacy and safety of dulaglutide when used instead of sitagliptin in type 2 diabetic patientsType 2 diabetes mellitusJPRN-UMIN000023245Iwasaki Naika Clinic40
招募中
不适用
Efficacy and safety of dulaglutide in the treatment of type 2 diabetesType 2 diabetes mellitus patientsJPRN-UMIN000027255Department of nephrology, Matsunami general hospital30
未知
4 期
A Phase 4 Study of Dulaglutide When Added to Insulin Treatment in Patients With Type 2 DiabetesType 2 DiabetesJPRN-jRCT1080223318Eli Lilly Japan K.K.
已完成
不适用
Safety and efficacy of dulaglutide therapy for the inpatient management of general medicine patients with type 2 diabetesType 2 diabetesJPRN-UMIN000025006Ichinomiyanishi hospital40